Objective: Dysregulation of dopaminergic neurotransmission at the D 1 receptor in the prefrontal cortex has been implicated in the pathogenesis of schizophrenia. Genetic polymorphisms of the dopamine D 1 -receptor gene have a plausible role in modulating the risk of schizophrenia. To determine the role of DRD1 genetic polymorphisms as a risk factor for schizophrenia, we undertook a case-control study to look for an association between the DRD1 gene and schizophrenia.
Introduction
Schizophrenia is a common mental disorder effected by the mutual influence of multiple genetic 1 and environmental factors, 2 and its heritability is up to 80%. 3 In order to clarify the pathological mechanisms, many studies have been carried out over the years, but a consistent conclusion has still not been achieved. To date, dysregulation of dopaminergic neurotransmission has been implicated in the pathogenesis of schizophrenia. 4, 5 The reduction of prefrontal cortical dopamine neurotransmission likely leads to schizophrenia. 6 Dopamine is an important endogenous neurotransmitter that plays a significant role in modulating cognitive, mood, and motor functions of the brain. 7 It plays a regulatory function by binding to the dopamine receptors of the postsynaptic membrane. The sequence of the dopamine D 1 receptor gene (DRD1) has been identified and mapped rs4532  rs5326  rs193082222   rs265981  rs201089398  rs35916350  rs146439723  rs10078714  rs10063995  rs10078866  rs267410  rs4532  rs5326  rs193082222   rs265981  rs201089398  rs35916350  rs146439723  rs10078714  rs10063995  rs10078866  rs267410 Block 1 (1 kb) Cases (r 2 ) Cases (D′) Controls (r 2 ) Controls (D′) 87   70   74   70   76  77   71   67   69   47   83   4  5  6  7  1  2  3  4  5  6  7  8  9  10  11   1  2  3  4  5  6  7  8  9  10  11   1  2  3  4  5  6  7  8  9  10  11   8  9  10  11 Block 1 (1 kb) Block 1 (1 kb) Block 1 (1 kb) Figure 2 Linkage-disequilibrium diagram of eleven single-nucleotide polymorphism loci in DRD1. The top row represents the disease group, while the bottom shows the control group; the left is r 2 , and the right is D′. The black grid represents r 2 =1; the blank grid represents D′=1.
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Yao et al to chromosome 5q35.1. 8 Linkage between DRD1 and schizophrenia has been reported in Chinese, 9 American, 10 and Portuguese populations. 11 As we all know, a remarkable symptom of schizophrenia patients is cognitive dysfunction (such as attention-deficit and memory disorders). 6, 12 Interestingly, an optimal amount of DRD1 stimulation is essential in maintaining normal prefrontal cognitive function. 13 rs4867798) has reported that rs11746641 and rs11749676 are associated with schizophrenia in males, and the haplotype T-A-T-C-T can reduce the risk of schizophrenia. 19 The genetic polymorphism of rs4532 is likely associated with deficits in executive function and performance on the Wisconsin Card Sorting Test. 6 However, no association between rs4532 and schizophrenia has been reported, 20, 21 and a consistent conclusion has still not been achieved.
Many previous studies analyzed a few loci (one to five SNPs) or selected several tag SNPs as a substitute for the entire gene region. However, the limitation of several loci could not completely pinpoint the true susceptible SNPs, owing to the weak linkage disequilibrium in the DRD1 gene. Most likely, the basis of inconsistent results was due to this factor. We analyzed eleven SNPs in the 5′-flanking and untranslated regions of the DRD1 gene by deoxyribonucleic acid (DNA) sequencing, and carried out a case-control study between 173 paranoid schizophrenia patients and 213 unrelated healthy controls. 22 on the basis of unstructured interviews and information from medical records. The study protocol and process was assessed and approved by the ethics committee at China Medical University. In the present study, all subjects signed the informed consent form.
Materials and methods Samples
Selection of polymorphic loci
Polymerase chain reaction (PCR) was used to amplify DRD1 fragment length, including 5′-flanking and untranslated regions. The nucleotide position of one fragment amplified was from -3,052 to -1,483 (primer sequence [forward] -ctgatatggtgcatggctgtt, [reverse] -acctgcgttgtctccaagtgt). The nucleotide position of the other fragment amplified was from -1,505 to +100 (primer sequence [forward] -ggacacttggagacaacgcag, [reverse] -atgagcagcgacaggaaacag). The amplified fragment included 45 SNP loci that had been reported in the National Center for Biotechnology Information database (www.ncbi.nlm.nih.gov/gene/), 39 and were genotyped by DNA sequencing. The frequencies of the SNP loci (.1%) were screened. Eleven polymorphic loci were detected in the northern Han Chinese population, including one newly discovered SNP loci: ss492961114/rs201089398 in the 5′ regulatory region. A schematic diagram for DRD1 is shown in Figure 1 .
Genotyping
Genomic DNA was extracted by the traditional phenolchloroform method and quantified with ultraviolet (UV) spectrophotometry. An ABI9700 amplif ier (Applied Biosystems, Foster City, CA, USA) was used to amplify the Neuropsychiatric Disease and Treatment 2014:10 Unconditional logistic regression models were used to obtain maximum-likelihood estimates of odds ratios (ORs) and their 95% confidence intervals (CIs) between each locus and the presence of paranoid schizophrenia. The Bonferroni correction was used in multiple testing, and P-values were divided by the total number of loci or haplotypes.
Results
Haploview 4.1 was used to test genotype fitness for the control and paranoid schizophrenic groups. The results showed that the distribution of no genotype frequencies at all loci deviated from the Hardy-Weinberg equilibrium in either group or in the male and female subgroups (P.0.05). Results of linkage analysis for control and disease groups are shown in Figure 2 .
Genotype and allele frequencies of eleven SNP loci in DRD1 are shown in Table 1 . The χ 2 test was used to measure the association of paranoid schizophrenic risk with DRD1 genotypes. Among them, the genotype distribution of rs5326 was statistically different between paranoid schizophrenia patients and controls (P=0.036), though the difference was lost after Bonferroni correction. Compared with the AA genotype, the AG + GG genotype reduced the disease risk (OR AG + GG 0.358, 95% CI AG + GG 0.151-0.851). In addition, a lower risk of paranoid schizophrenia was associated with the AG + GG genotype of rs4532 (OR AG + GG 0.592, 95% CI AG + GG 0.350-1.001) compared with the AA genotype. No remaining loci exhibited significant differences in allele or genotype frequencies between the patients and controls.
A comparison of the frequencies of haplotypes formed by the seven SNPs in the block was analyzed between the patients and controls. The results are shown in Table 2 . The remaining four SNPs outside the block formed the haplotypes, and the result is shown in Table 3 . All-haplotype analysis found that there was no association with the occurrence of paranoid schizophrenia between patients and controls. A study reported that sexually dimorphic DRD1 SNPs impacted on the risk of schizophrenia. 19 Therefore, we stratified the observed association of rs5326 and rs4532 with the risk of paranoid schizophrenia based on sex by the χ 2 test (results shown in Table 4 ). In males, the genotype distribution of rs5326 was statistically different between cases and controls (P=0.048). In females, the genotype distribution of rs4532 was statistically different between cases and controls (P=0.029). However, these significant differences disappeared after Bonferroni correction.
Discussion
In the present study, we investigated eleven SNPs in the DRD1 gene in a northern Chinese Han population by DNA sequencing. There were no significant differences in allele, genotype, or haplotype frequencies between paranoid schizophrenia patients and controls after Bonferroni correction. Consistent with our results, some studies reported no significant association between the DRD1 gene and schizophrenia. 20, 23 However, several previous studies have reported that the DRD1 gene is associated with bipolar disorder, 21 attention deficit with hyperactivity disorders, 24 nicotine dependence, 25 alcohol dependence, 26 and others. Compared with these diseases, schizophrenic patients have the same or similar symptoms.
Our results found that the AG + GG genotype of rs5326, as a protective factor for schizophrenia, could reduce the risk of paranoid schizophrenia, as assessed by the χ 2 test. Zhu et al 27 reported that rs5326 was not associated with schizophrenia in the Chinese Han population, which was consistent with previous studies. 28, 29 The interaction between the DNMT3B and DRD1 genes significantly increased the risk of schizophrenia after analysis with multifactor dimensionality reduction software. 29 This also shows that the incidence of schizophrenia is affected by the interaction of multiple genes, and studies of only one gene cannot clearly explain the pathogenesis. Although some studies 20, 26, 30 found no association between rs4532 and schizophrenia, a meta-analysis 31 indicated that DRD1 might contain a genuine susceptibility allele, and the OR of rs4532 reached 1.18 (95% CI 1.01-1.38). In addition, rs4532 was associated with antipsychotic treatment in schizophrenia 32, 33 and working memory and cognitive behavior related to the prefrontal cortex. 6, 13 This shows that rs4532 likely has a potential link with the etiology of schizophrenia. Furthermore, the inconsistency of association studied between DRD1 and schizophrenia may result from genetic heterogeneity, which is an important challenge in the genetic study of schizophrenia. In our study, we reported rs201089398 for the first time. However, this new locus had a slightly lower frequency, and we failed to reveal its potential association with schizophrenia in the Chinese Han population.
The pathogenesis of schizophrenia is the participation of a variety of risk factors, and sex is an important factor. 34, 35 Our study showed that rs5326 was statistically different between cases and controls in males and rs4532 was statistically different between cases and controls in females by the χ 2 test. Unfortunately, the impact of sex-specific mechanisms in schizophrenia is unclear, and needs further exploration in the future. In addition, there was another limitation in our study in that we did not analyze positive and negative symptoms or cognitive performance of the patients, owing to the lack of original information.
What can we learn from these results? First, the analysis of just one gene is far from enough, because DRD1 may 
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polymorphism and paranoid schizophrenia result in schizophrenia by interacting with other dopaminergic-related genes, such as synthase genes, metabolic genes, transporter genes, and others. Additionally, other neurotransmitters are also involved in the pathogenesis of schizophrenia. We cannot definitively rule out a role for any of these genes in schizophrenia. Therefore, further studies should be focused on genome-wide SNP analysis and genegene interactions to determine their possible roles in the etiology of schizophrenia.
Second, multiethnic studies with large samples are essential. Many of the ORs for association are in a plausible range (1.10-1.23) for small susceptibility effects, but below what would produce significant P-values in smaller samples. 36 The larger ORs in some previous reports may either be false positives or inflated estimates of genetic effects, while association studies of large samples provide more power. In the present study, we reported rs201089398 for the first time. With regard to the limited samples, the slightly lower frequency of this new locus might not reveal the potential association with schizophrenia in the Chinese Han population. Besides, our results demonstrated that the genotype frequencies of DRD1 are variable in different ethnic groups. Therefore, through multiethnic studies, it will likely be easier to find a genetic effect for susceptibility to schizophrenia.
Third, genetic heterogeneity is a significant challenge in the study of schizophrenia, 37 and family-based studies could overcome this problem effectively. 38 Our results need to be clarified through analysis of extensive family studies. Additionally, paranoid schizophrenia, as a subtype of schizophrenia, includes positive and negative symptoms, which show different clinical manifestations. Unfortunately, due to the limited data, we did not do a more detailed analysis. Overall, the shortcomings of our study could partially inform future researchers.
In summary, although our study did not find a genetic association between DRD1 and paranoid schizophrenia, its possible role in the risk of schizophrenia cannot be definitively excluded. Further and larger studies are necessary to evaluate the effect of DRD1 polymorphisms on the etiology of schizophrenia, and our data may provide a reference.
